KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Cash from Operations (2017 - 2025)

Twist Bioscience (TWST) has disclosed Cash from Operations for 7 consecutive years, with 20704000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Cash from Operations fell 1534.1% to 20704000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was 142474000.0, a 14.54% decrease, with the full-year FY2025 number at 47628000.0, up 25.69% from a year prior.
  • Cash from Operations was 20704000.0 for Q3 2023 at Twist Bioscience, up from 23412000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1267000.0 in Q3 2022 to a low of 58671000.0 in Q1 2020.
  • A 5-year average of 30926894.74 and a median of 25202000.0 in 2020 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: skyrocketed 96.36% in 2022, then tumbled 1534.1% in 2023.
  • Twist Bioscience's Cash from Operations stood at 34914000.0 in 2019, then increased by 28.59% to 24932000.0 in 2020, then plummeted by 87.12% to 46653000.0 in 2021, then fell by 15.9% to 54070000.0 in 2022, then skyrocketed by 61.71% to 20704000.0 in 2023.
  • Per Business Quant, the three most recent readings for TWST's Cash from Operations are 20704000.0 (Q3 2023), 23412000.0 (Q2 2023), and 44288000.0 (Q1 2023).